Aim of the study is to determine which instruments for monitoring the depth of palliative sedation are most reliable, and/or adequately measure the severity of treated symptoms.
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
terminale patiënten met diverse ethiologieën
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Depth of sedation
Secondary outcome
Interrater reliability, internal consistency of the measurement scales.
Background summary
The past few years there has been a vivid discussion about palliative sedation.
This discussion focuses on the criteria and conditions required for palliative
sedation, but also concerns the relation between palliative sedation and
euthanasia.
Controversially, research points out that palliative sedation is not always
carried out in the dying phase and sometimes palliative sedation is applied
with the explicit aim of hastening the death of the patient. A committee
appointed by the Royal Dutch Medical Association (KNMG) developed a guideline
palliative sedation which was implemented in December 2005. The guideline has
been established in order to promote the correct application of palliative
sedation.
Until now the current practice of the palliative sedation has not yet been
examined fully. It is of great importance that besides a correct indication,
the degree of sedation is reached which has been considered necessary and
sufficient for the desired degree of symptom suppression of the individual
patient. The degree of symptom control stipulates the doses of a sedatives. The
KNMG guideline however contains no clear regulations for clinical monitoring of
the depth of sedation. This can lead to serious problems, such as an
unintentional awakening of the patient.
Study objective
Aim of the study is to determine which instruments for monitoring the depth of
palliative sedation are most reliable, and/or adequately measure the severity
of treated symptoms.
Study design
Observational design
Study burden and risks
The study is considered observational and will not take invasive measurements.
No risks have been link to this study.
De Boelelaan 1117
1081 HV Amsterdam
NL
De Boelelaan 1117
1081 HV Amsterdam
NL
Listed location countries
Age
Inclusion criteria
* Life expectancy less than 2 weeks.
* No treatment available or treatment is harmful.
* Patient is suffering from refractory symptoms.
Exclusion criteria
- no informed consent
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL23542.029.08 |